Overview
-$34.2MNet income, fiscal 20252
- TickerPYPD on Nasdaq1
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersL31
- Incorporated inIsrael3
- Business address18 Hasivim Street, Petach Tikva, L3 49593763
- Filer categoryNon-accelerated filer3
- Legal formCorporation
See how the biggest companies compare on our leaderboards
SEC as frequently or as promptly as U.S. domestic companies registered under the Exchange Act.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Research and development | $23.8M | $22.8M | $16.1M |
| Marketing and business development | $2.0M | $945.0K | $1.2M |
| General and administrative | $7.2M | $4.3M | $5.5M |
| Operating loss | $33.0M | $28.0M | $22.9M |
| Loss on extinguishment of debt | $512.0K | ||
| Financial expense, net | $685.0K | $951.0K | $929.0K |
| Loss before income tax | $34.2M | $29.0M | $23.8M |
| Income tax expense | $5.0K | $42.0K | $69.0K |
| Net loss | $34.2M | $29.0M | $23.9M |
| Basic (in Dollars per share) | $2.09 | $4.91 | $16.99 |
| Diluted (in Dollars per share) | $2.09 | $4.91 | $16.93 |
| Basic (in Shares) | 16.4M shares | 5.9M shares | 1.4M shares |
| Diluted (in Shares) | 16.4M shares | 5.9M shares | 1.4M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $6.4M | $15.6M | $5.3M | |
| Restricted deposits | $193.0K | $168.0K | ||
| Short-term deposits | $6.5M | |||
| Pre-launch inventories | $1.1M | |||
| Prepaid expenses and other current assets | $995.0K | $764.0K | ||
| Total current assets | $15.2M | $16.6M | ||
| Property and equipment, net | $5.1M | $6.1M | ||
| Operating lease right-of-use assets | $1.7M | $2.3M | ||
| Other long-term assets | $311.0K | $277.0K | ||
| Total long-term assets | $7.1M | $8.6M | ||
| Total assets | $22.3M | $25.2M | ||
| Trade payables | $2.9M | $2.4M | ||
| Accrued expenses and other current liabilities | $2.7M | $2.6M | ||
| Current maturities of long-term debt | $988.0K | $6.8M | ||
| Current maturities of operating lease liabilities | $1.2M | $919.0K | ||
| Total current liabilities | $7.7M | $12.7M | ||
| Long-term debt | $634.0K | |||
| Deferred revenues | $2.5M | $2.5M | ||
| Long-term operating lease liabilities | $647.0K | $1.3M | ||
| Other liabilities | $400.0K | $396.0K | ||
| Total long-term liabilities | $3.6M | $4.9M | ||
| Additional paid-in capital | $312.5M | $275.0M | ||
| Accumulated deficit | -$301.5M | -$267.3M | ||
| Total shareholders equity | $11.0M | $7.7M | -$2.1M | $5.8M |
| Total liabilities and shareholders equity | $22.3M | $25.2M | ||
| Ordinary shares, shares authorized (in Shares) | 107.8M shares | 107.8M shares | ||
| Ordinary shares, shares issued (in Shares) | 18.2M shares | 10.2M shares | ||
| Ordinary shares, shares outstanding (in Shares) | 18.2M shares | 10.2M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $6.4M | $15.6M | $5.3M | |
| Restricted deposits | $193.0K | $168.0K | ||
| Short-term deposits | $6.5M | |||
| Pre-launch inventories | $1.1M | |||
| Prepaid expenses and other current assets | $995.0K | $764.0K | ||
| Total current assets | $15.2M | $16.6M | ||
| Property and equipment, net | $5.1M | $6.1M | ||
| Operating lease right-of-use assets | $1.7M | $2.3M | ||
| Other long-term assets | $311.0K | $277.0K | ||
| Total long-term assets | $7.1M | $8.6M | ||
| Total assets | $22.3M | $25.2M | ||
| Trade payables | $2.9M | $2.4M | ||
| Accrued expenses and other current liabilities | $2.7M | $2.6M | ||
| Current maturities of long-term debt | $988.0K | $6.8M | ||
| Current maturities of operating lease liabilities | $1.2M | $919.0K | ||
| Total current liabilities | $7.7M | $12.7M | ||
| Long-term debt | $634.0K | |||
| Deferred revenues | $2.5M | $2.5M | ||
| Long-term operating lease liabilities | $647.0K | $1.3M | ||
| Other liabilities | $400.0K | $396.0K | ||
| Total long-term liabilities | $3.6M | $4.9M | ||
| Additional paid-in capital | $312.5M | $275.0M | ||
| Accumulated deficit | -$301.5M | -$267.3M | ||
| Total shareholders equity | $11.0M | $7.7M | -$2.1M | $5.8M |
| Total liabilities and shareholders equity | $22.3M | $25.2M | ||
| Ordinary shares, shares authorized (in Shares) | 107.8M shares | 107.8M shares | ||
| Ordinary shares, shares issued (in Shares) | 18.2M shares | 10.2M shares | ||
| Ordinary shares, shares outstanding (in Shares) | 18.2M shares | 10.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$34.2M | -$29.0M | -$23.9M |
| Depreciation of property and equipment | $1.5M | $1.6M | $1.8M |
| Remeasurement of warrants | -$201.0K | ||
| Non-cash financial expenses, net | $213.0K | $697.0K | $1.7M |
| Loss on extinguishment of debt | $512.0K | ||
| Share-based compensation expenses | $4.9M | $2.8M | $3.4M |
| Pre-launch inventories | -$1.1M | ||
| Prepaid expenses and other assets | -$225.0K | -$315.0K | $641.0K |
| Operating lease right-of-use assets | $907.0K | $824.0K | $593.0K |
| Operating lease liabilities | -$675.0K | -$723.0K | -$494.0K |
| Trade payables | $180.0K | $1.6M | -$369.0K |
| Accrued expenses and other liabilities | $172.0K | $493.0K | -$481.0K |
| Net cash used in operating activities | -$27.9M | -$22.0M | -$17.2M |
| Investment in bank deposits | -$26.2M | -$21.4M | -$18.6M |
| Proceeds from bank deposits | $19.7M | $21.1M | $22.6M |
| Purchase of property and equipment | -$210.0K | -$76.0K | -$196.0K |
| Net cash provided (used in) by investing activities | -$6.7M | -$330.0K | $3.8M |
| Proceeds from exercise of options | $1.0K | $9.0K | |
| Proceeds from issuance of ordinary shares, warrants, pre-funded warrants and abeyance shares, net | $32.6M | $35.9M | $12.7M |
| Payment due to long-term debt | -$6.4M | -$3.3M | -$2.6M |
| Payment of fees due to debt | -$859.0K | -$125.0K | -$125.0K |
| Net cash provided by financing activities | $25.4M | $32.4M | $10.0M |
| Increase (decrease) in cash, cash equivalents and restricted deposits | -$9.2M | $10.1M | -$3.5M |
| Interest paid | $557.0K | $950.0K | $1.0M |
| Cash paid during the year for income taxes | $5.0K | $3.0K | $18.0K |
| Property and equipment acquired by credit | $267.0K | ||
| Right-of-use asset recognized with corresponding lease liability | $287.0K | $1.5M | $241.0K |
| Credit line derivative | $100.0K | $127.0K | |
| Modification of warrants | $31.0K | ||
| Warrants issued as part of credit line | $115.0K |
No quarter-by-quarter statement was filed.
Corporate structure
PolyPid Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of PolyPid Ltd.
- Centaurus Investments Ltd Filed SCHEDULE 13G/A on PolyPid Ltd., latest Aug 13, 2026 (4 filings since Sep 20, 2023)
- Rosalind Advisors, Inc. Filed SCHEDULE 13G/A on PolyPid Ltd., latest Aug 12, 2026 (10 filings since Mar 1, 2024)
- Aurum Ventures M.K.I. Ltd. Filed SCHEDULE 13G/A on PolyPid Ltd., latest May 4, 2026 (7 filings since Feb 24, 2022)
- Orin Hirschman Filed SCHEDULE 13G/A on PolyPid Ltd., latest Jan 30, 2026 (2 filings since Jul 29, 2025)
- Aharon Lukach Filed SCHEDULE 13G/A on PolyPid Ltd., latest May 28, 2025 (3 filings since Apr 17, 2024)
- Yehuda Nir Filed SCHEDULE 13G/A on PolyPid Ltd., latest May 15, 2025 (3 filings since Apr 5, 2024)
- Gabriel Capital Management Ltd. Filed SC 13G/A on PolyPid Ltd., latest Feb 10, 2023 (2 filings since Feb 10, 2022)
- PolyPid Ltd. L3
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What PolyPid Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $16.0M2 Dec 31, 2025 | $15.5M2 Dec 31, 2024 | +3.1% |
| Accumulated depreciation | $10.9M2 Dec 31, 2025 | $9.4M2 Dec 31, 2024 | +15.5% |
| Property and equipment, net | $5.1M2 Dec 31, 2025 | $6.1M2 Dec 31, 2024 | −16.1% |
| Operating-lease assets (leased space) | $1.7M2 Dec 31, 2025 | $2.3M2 Dec 31, 2024 | −27.0% |
Investments
Leadership
Who has led PolyPid Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerDalit Fellous Hazan Mar 18, 2026 to now10
- Chief executive officerDikla Czaczkes Akselbrad Mar 18, 2026 to now11
- Chief financial officerJonathan Missulawin Mar 23, 2026 to now12
- Chief operating officerOri Warshavsky Mar 26, 2026 to now13
Board members and other officers (6)
- Board memberBrooke Story Mar 18, 2026 to now14
- Board memberDikla Czaczkes Akselbrad Mar 18, 2026 to now11
- Board memberItzhak Krinsky Mar 18, 2026 to now15
- Board memberJoseph Benamram Mar 23, 2026 to now16
- Board memberYechezkel Barenholz Mar 23, 2026 to now17
- Board memberNir Dror-Darwish Mar 26, 2026 to now18
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive OfficerJonny Missulawin named Jan 22, 2024 to Jun 23, 202519
- DirectorJacob Harel named Jan 22, 2024 to Jun 23, 202519
- DirectorNir Dror named Jan 22, 2024 to Jun 23, 202519
- DirectorNurit Tweezer-Zaks named Jan 22, 2024 to Jun 23, 202519
- DirectorRobert B. Stein named Jan 22, 2024 to Jun 23, 202519
- DirectorYitzchak Jacobovitz named Jun 23, 202519
- DirectorYossi BenAmram named Jan 22, 2024 to Jun 23, 202519
Timeline
Calendar
Coming up
- Nov 11, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.37) a share, on Nov 12, 2025.20
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
191 filings to the SEC since October 2021: 5 annual reports, 21 insider forms, 31 large holders, 4 private raises, 130 other. The latest 20:
- Oct 1, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Oct 1, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 13, 2026SCHEDULE 13G/A EDGAR
- Aug 12, 2026SCHEDULE 13G/A EDGAR
- Aug 12, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 12, 2026S-8 REGISTRATION STATEMENT EDGAR
- Aug 12, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 21, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 17, 20264 EDGAR
- Jul 17, 20264 EDGAR
- Jul 17, 20264 EDGAR
- Jul 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 17, 20264 EDGAR
- Jul 17, 20264 EDGAR
- Jul 17, 20264 EDGAR
- Jul 15, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
The 191 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Centaurus Investments LtdSCHEDULE 13G/A, 4 filings Sep 20, 2023 to Aug 13, 202621
- Rosalind Advisors, Inc.SCHEDULE 13G/A, 10 filings Mar 1, 2024 to Aug 12, 202622
- Aurum Ventures M.K.I. Ltd.SCHEDULE 13G/A, 7 filings Feb 24, 2022 to May 4, 202623
- Orin HirschmanSCHEDULE 13G/A, 2 filings Jul 29, 2025 to Jan 30, 202624
- Aharon LukachSCHEDULE 13G/A, 3 filings Apr 17, 2024 to May 28, 202525
- Yehuda NirSCHEDULE 13G/A, 3 filings Apr 5, 2024 to May 15, 202526
- Gabriel Capital Management Ltd.SC 13G/A, 2 filings Feb 10, 2022 to Feb 10, 202327
Money raised
Private offerings the company reported to the SEC on Form D.
- Jun 16, 2025Raised $26.7 million in a private offering of equity Form D: 20 investors so far Form D
- Dec 26, 2024Raised $14.5 million in a private offering of equity Form D: 12 investors so far Form D
- Aug 6, 2024Raised $14.2 million in a private offering of equity Form D: 17 investors so far Form D
- Jan 9, 2024Raised $35 million in a private offering of equity Form D: 20 investors so far Form D
SEC filer profile
How PolyPid Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARPolyPid Ltd.1
- CIK0001611842
- Filer statusNon-accelerated filer not an emerging growth company; not a shell company4
- Incorporated inIsrael4
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address18 Hasivim Street, Petach Tikva, L3 49593761
- Phone972-74-71957001
- Shares outstanding18,204,002 shares as of Dec 31, 20254
- AuditorKOST FORER GABBAY & KASIERER, Haifa, Israel PCAOB ID 1281; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceJul 8, 20141
- Filings253 in all: 6-K (117), SCHEDULE 13G/A (15), 3 (11), CORRESP (11), 4 (10), SC 13G/A (10), UPLOAD (9), EFFECT (7)1
All 30 form types
20-F (6), D (6), F-3 (6), S-8 (6), SC 13G (6), F-1/A (5), 424B5 (3), DRS (3), DRS/A (3), F-1 (3), 424B3 (2), 8-A12B (2), CERT (2), RW (2), 424B4 (1), 6-K/A (1), CB (1), DRSLTR (1), F-1MEF (1), F-X (1), FWP (1), SCHEDULE 13G (1)
- Latest filingsAnnual report (20-F) Feb 25, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Ordinary Shares, no par value | PYPD | Nasdaq |
From the cover page of the 20-F filed Feb 25, 2026 (Section 12(b) of the Exchange Act).4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPolyPid Ltd. filings on SEC EDGAR
- 2SEC EDGARPolyPid Ltd. 10-K for fiscal 2025
- 3SEC EDGARPolyPid Ltd. filings on SEC EDGAR
- 4
- 5SEC EDGARPolyPid Ltd. 10-K for fiscal 2018
- 6SEC EDGARPolyPid Ltd. 10-K for fiscal 2019
- 7SEC EDGARPolyPid Ltd. 10-K for fiscal 2020
- 8SEC EDGARPolyPid Ltd. 10-K for fiscal 2021
- 9SEC EDGARPolyPid Ltd. 10-K for fiscal 2022
- 10
- 11
- 12
- 13
- 14SEC EDGARBrooke Story, Board member
- 15SEC EDGARItzhak Krinsky, Board member
- 16SEC EDGARJoseph Benamram, Board member
- 17SEC EDGARYechezkel Barenholz, Board member
- 18SEC EDGARNir Dror-Darwish, Board member
- 19
- 20NasdaqNasdaq calendar
- 21
- 22
- 23
- 24
- 25
- 26
- 27